Niels Boone speaks to ecancer at the 2019 Biosimilars Educational Advanced Masterclass for Pharmacists (P-BEAM) in Zurich about the assessing biosimilars in the real-world setting.

He mentions the selection criteria for the biosimilar products and the reference products and the attitudes of patients during the course of their treatments.

Boone also describes some of the challenges faced when using biosimilars in a real-world setting and how he envisions the future use of these agents in this setting.

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.

If you would like to learn more about biosimilar medicines, please visit our free e-learning modules here.